Fragility Index and Fragility Quotient in Randomized Controlled Trials on Corticosteroids in ARDS Due to COVID-19 and Non-COVID-19 Etiology
出版年份 2021 全文链接
标题
Fragility Index and Fragility Quotient in Randomized Controlled Trials on Corticosteroids in ARDS Due to COVID-19 and Non-COVID-19 Etiology
作者
关键词
-
出版物
Journal of Clinical Medicine
Volume 10, Issue 22, Pages 5287
出版商
MDPI AG
发表日期
2021-11-15
DOI
10.3390/jcm10225287
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Corticosteroids in COVID-19 and non-COVID-19 ARDS: a systematic review and meta-analysis
- (2021) Dipayan Chaudhuri et al. INTENSIVE CARE MEDICINE
- Fragility Index in Multicenter Randomized Controlled Trials in Critical Care Medicine That Have Shown Reduced Mortality
- (2020) Maria Vargas et al. CRITICAL CARE MEDICINE
- Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial
- (2020) Jesús Villar et al. Lancet Respiratory Medicine
- Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions
- (2020) Yvan Jamilloux et al. AUTOIMMUNITY REVIEWS
- Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With COVID-19 (Metcovid): A Randomised, Double-Blind, Phase IIb, Placebo-Controlled Trial
- (2020) Christiane Maria Prado Jeronimo et al. CLINICAL INFECTIOUS DISEASES
- Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19
- (2020) Pierre-François Dequin et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19
- (2020) Bruno M. Tomazini et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19
- (2020) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The weakness of fragility index exposed in an analysis of the traumatic brain injury management guidelines: A meta-epidemiological and simulation study
- (2020) Thomas M. Condon et al. PLoS One
- Epinephrine for out of hospital cardiac arrest: A systematic review and meta-analysis of randomized controlled trials
- (2019) Vargas Maria et al. RESUSCITATION
- Strength in numbers? The fragility index of studies from the Scandinavian knee ligament registries
- (2019) Eleonor Svantesson et al. KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY
- Systematic Evaluation of the Robustness of the Evidence Supporting Current Guidelines on Myocardial Revascularization Using the Fragility Index
- (2019) Mario Gaudino et al.
- P-values and significance: The null hypothesis that they are not related is correct
- (2019) Sharon Einav et al. JOURNAL OF CRITICAL CARE
- The Fragility and Reliability of Conclusions of Anesthesia and Critical Care Randomized Trials With Statistically Significant Findings
- (2018) François Grolleau et al. CRITICAL CARE MEDICINE
- The End of Corticosteroid in Sepsis
- (2018) Maria Vargas et al. CRITICAL CARE MEDICINE
- The Fragility Index in Randomized Clinical Trials as a Means of Optimizing Patient Care
- (2018) Christopher J. Tignanelli et al. JAMA Surgery
- The ASA's Statement onp-Values: Context, Process, and Purpose
- (2016) Ronald L. Wasserstein et al. AMERICAN STATISTICIAN
- The Fragility Index in Multicenter Randomized Controlled Critical Care Trials*
- (2016) Elliott E. Ridgeon et al. CRITICAL CARE MEDICINE
- The statistical significance of randomized controlled trial results is frequently fragile: a case for a Fragility Index
- (2014) Michael Walsh et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- PEEP Role in ICU and Operating Room: From Pathophysiology to Clinical Practice
- (2014) M. Vargas et al. TheScientificWorldJOURNAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started